Anda Sampetrean
YOU?
Author Swipe
View article: Palliative semi-permanent abdominal drain for the management of refractory malignant ascites: a retrospective study in a comprehensive cancer center
Palliative semi-permanent abdominal drain for the management of refractory malignant ascites: a retrospective study in a comprehensive cancer center Open
View article: Precision medicine’s new frontier: integrating palliative care at the right time
Precision medicine’s new frontier: integrating palliative care at the right time Open
In recent decades, the field of oncology has evolved in parallel with advancements in palliative care. The multifaceted demands of cancer treatment—including symptom management, psychosocial support, and other related care components—requi…
View article: Contribution of Collegial Support Meetings (CSM) in the management of complex situations of patients with advanced cancer
Contribution of Collegial Support Meetings (CSM) in the management of complex situations of patients with advanced cancer Open
Purpose Collegial Support Meetings (CSM) have been set up in the Gustave Roussy Cancer hospital for inpatients whose complex care requires a multi-professional approachinvolving participants from various fields. CSMs are composed not only …
View article: Use of the PALLIA 10 Score in Patients Enrolled in Phase I Trials at Gustave Roussy Cancer Center
Use of the PALLIA 10 Score in Patients Enrolled in Phase I Trials at Gustave Roussy Cancer Center Open
Background Early phase clinical trials usually include patients with advanced disease who have failed standard therapies. Early palliative care for these patients has shown to improve quality of life and even survival. PALLIA 10 score (ran…
View article: Immune-related adverse events (irAEs) and outcome in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts) treated by immune-checkpoints inhibitors (ICI)
Immune-related adverse events (irAEs) and outcome in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts) treated by immune-checkpoints inhibitors (ICI) Open